251 related articles for article (PubMed ID: 30822350)
1. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.
Cone EB; Marchese M; Paciotti M; Nguyen DD; Nabi J; Cole AP; Molina G; Molina RL; Minami CA; Mucci LA; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Dec; 3(12):e2030072. PubMed ID: 33315115
[TBL] [Abstract][Full Text] [Related]
3. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
4. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.
Sheni R; Qin J; Viswanathan S; Castellucci E; Kalnicki S; Mehta V
JCO Oncol Pract; 2023 Jun; 19(6):e904-e915. PubMed ID: 37001038
[TBL] [Abstract][Full Text] [Related]
7. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
8. Association of Medicaid expansion with 2-year survival and time to treatment initiation in gastrointestinal cancer patients: A National Cancer Database study.
Mobley EM; Chen G; Xu J; Edgar L; Pather K; Daly MC; Awad ZT; Parker AS; Xie Z; Suk R; Mathews S; Hong YR
J Surg Oncol; 2023 Dec; 128(8):1285-1301. PubMed ID: 37781956
[TBL] [Abstract][Full Text] [Related]
9. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
Ogura K; Fujiwara T; Healey JH
Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
[TBL] [Abstract][Full Text] [Related]
10. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.
Yusuf M; Gaskins J; Tennant P; Bumpous J; Dunlap N
Pract Radiat Oncol; 2019; 9(4):e372-e385. PubMed ID: 30926480
[TBL] [Abstract][Full Text] [Related]
11. Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
Curtis GL; Lawrenz JM; George J; Styron JF; Scott J; Shah C; Shepard DR; Rubin B; Nystrom LM; Mesko NW
J Surg Oncol; 2018 Jun; 117(8):1776-1785. PubMed ID: 29949654
[TBL] [Abstract][Full Text] [Related]
12. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
14. Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.
Frosch ZAK; Illenberger N; Mitra N; Boffa DJ; Facktor MA; Nelson H; Palis BE; Bekelman JE; Shulman LN; Takvorian SU
JAMA Netw Open; 2021 Jul; 4(7):e2115675. PubMed ID: 34241630
[TBL] [Abstract][Full Text] [Related]
15. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.
Grønhøj C; Jensen D; Dehlendorff C; Nørregaard C; Andersen E; Specht L; Charabi B; von Buchwald C
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):375-381. PubMed ID: 29526405
[TBL] [Abstract][Full Text] [Related]
16. Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.
Gbolahan O; Hashemi-Sadraei N; Yash S; Williams G; Ramachandran R; Kim YI; Paluri R; Outlaw D; El-Rayes B; Nabell L
Cancer Med; 2023 Feb; 12(3):3488-3498. PubMed ID: 35979540
[TBL] [Abstract][Full Text] [Related]
17. Determinants of survival in older cancer patients.
Goodwin JS; Samet JM; Hunt WC
J Natl Cancer Inst; 1996 Aug; 88(15):1031-8. PubMed ID: 8683633
[TBL] [Abstract][Full Text] [Related]
18. Hepatopancreatobiliary malignancies: time to treatment matters.
Kerekes DM; Frey AE; Bakkila BF; Johnson CH; Becher RD; Billingsley KG; Khan SA
J Gastrointest Oncol; 2023 Apr; 14(2):833-848. PubMed ID: 37201090
[TBL] [Abstract][Full Text] [Related]
19. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
20. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis.
Morse E; Fujiwara RJT; Judson B; Mehra S
Laryngoscope; 2018 Dec; 128(12):2751-2758. PubMed ID: 29756382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
